
BOSULIF
BOSUTINIB MONOHYDRATE
- 规格
- 100mg/500mg
- 制造商
- GLAXOSMITHKLINE Pharma
- 供应情况
- 可供采购
BOSUTINIB MONOHYDRATE 100mg/500mg — Tablet, 28's Strip

扫码添加微信
药品简介
Originator: BOSULIF by PF PRISM CV · Manufacturer: GLAXOSMITHKLINE Pharma. Indication & Dosage: BOSULIF (BOSUTINIB MONOHYDRATE), is a prescription medicine used to treat certain types of blood cancer (chronic myelogenous leukemia-CML). BOSUTINIB MONOHYDRATE also works for adult patients with Newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML). BOSULIF is Manufactured by GlaxoSmithKline Pharma Ltd. in Germany. BOSUTINIB MONOHYDRATE has to take orally once daily. Side Effects: The most common adverse reactions of BOSUTINIB MONOHYDRATE are: Nausea , vomiting , stomach / abdominal pain , loss of appetite, cough, joint pain, headache, or dizziness. The above information comes from the Internet. Please consult with doctor for medical advice.
适应症
本信息仅供参考,不构成医疗建议。请务必咨询合格的医疗专业人士。



